BioCentury | Nov 24, 2014
Company News

Nicox, OptiMed deal

Nicox granted OptiMed exclusive rights in Australia and New Zealand to distribute AdenoPlus and Xailin. AdenoPlus is an in vitro diagnostic that aids in the differential diagnosis of acute conjunctivitis, and Xailin a multidose carbomer...
BioCentury | Nov 13, 2014
Cover Story

Boosting adjuvants

For all the talk of new vaccines, not much attention has been paid to the need for better adjuvants, which have remained stuck on alum-based products for decades. The NIH is committing up to $70...
BioCentury | Oct 27, 2014
Company News

Nicox sales and marketing update

Nicox launched Xailin Gel in Europe to treat dry eye syndrome. The product is a multidose carbomer gel lubricant. Nicox S.A. (Euronext:COX), Sophia Antipolis, France Business: Ophthalmic WIR Staff Endocrine / Metabolic Ophthalmic...
BioCentury | Feb 14, 2008
Cover Story

New roadblock to HIV infection

The goal of developing an effective vaginal microbicide against HIV infection has eluded researchers ever since the first potential compound assessed, nonoxynol-9, proved to actually increase infection rates. In the Proceedings of the National Academy...
BioCentury | Apr 19, 1999
Company News

CarboMed other research news

...I studies to treat cancer and is in development with partner AstraZeneca PLC (London, U.K.). CarboMed Inc....
BioCentury | Jan 11, 1999
Tools & Techniques

'So long, and thanks for all the drugs'

...kinase inhibitor reduced edema and inflammation by 91 percent in mice. Throw down those crutches! CarboMed's...
BioCentury | Dec 14, 1998
Company News

CarboMed management update

CarboMed Inc., Brentwood, Tenn. Business: Cancer Hired: John Watson as president and CEO, formerly COO of GalaGen Inc. WIR Staff cancer...
BioCentury | Nov 2, 1998
Clinical News

CarboMed preclinical data

...is expected to enter the clinic in acute spinal injury by the end of 1999. CarboMed Inc....
BioCentury | Nov 2, 1998
Tools & Techniques

Angiogenesis agent shows healing properties

...cancer anti-angiogenesis shows exceptional promise as an all-around healer, allowing paralyzed mice to walk again. CarboMed Inc....
...a few days the receptors from embryonic angiogenesis that allow strep to attach and attack. CarboMed...
Items per page:
1 - 9 of 9
BioCentury | Nov 24, 2014
Company News

Nicox, OptiMed deal

Nicox granted OptiMed exclusive rights in Australia and New Zealand to distribute AdenoPlus and Xailin. AdenoPlus is an in vitro diagnostic that aids in the differential diagnosis of acute conjunctivitis, and Xailin a multidose carbomer...
BioCentury | Nov 13, 2014
Cover Story

Boosting adjuvants

For all the talk of new vaccines, not much attention has been paid to the need for better adjuvants, which have remained stuck on alum-based products for decades. The NIH is committing up to $70...
BioCentury | Oct 27, 2014
Company News

Nicox sales and marketing update

Nicox launched Xailin Gel in Europe to treat dry eye syndrome. The product is a multidose carbomer gel lubricant. Nicox S.A. (Euronext:COX), Sophia Antipolis, France Business: Ophthalmic WIR Staff Endocrine / Metabolic Ophthalmic...
BioCentury | Feb 14, 2008
Cover Story

New roadblock to HIV infection

The goal of developing an effective vaginal microbicide against HIV infection has eluded researchers ever since the first potential compound assessed, nonoxynol-9, proved to actually increase infection rates. In the Proceedings of the National Academy...
BioCentury | Apr 19, 1999
Company News

CarboMed other research news

...I studies to treat cancer and is in development with partner AstraZeneca PLC (London, U.K.). CarboMed Inc....
BioCentury | Jan 11, 1999
Tools & Techniques

'So long, and thanks for all the drugs'

...kinase inhibitor reduced edema and inflammation by 91 percent in mice. Throw down those crutches! CarboMed's...
BioCentury | Dec 14, 1998
Company News

CarboMed management update

CarboMed Inc., Brentwood, Tenn. Business: Cancer Hired: John Watson as president and CEO, formerly COO of GalaGen Inc. WIR Staff cancer...
BioCentury | Nov 2, 1998
Clinical News

CarboMed preclinical data

...is expected to enter the clinic in acute spinal injury by the end of 1999. CarboMed Inc....
BioCentury | Nov 2, 1998
Tools & Techniques

Angiogenesis agent shows healing properties

...cancer anti-angiogenesis shows exceptional promise as an all-around healer, allowing paralyzed mice to walk again. CarboMed Inc....
...a few days the receptors from embryonic angiogenesis that allow strep to attach and attack. CarboMed...
Items per page:
1 - 9 of 9